by Usha Govindarajulu | Aug 31, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
August 31, 2022 In a recent article in NEJM that appeared this month, researchers conducted a double-blind randomized placebo-controlled trial of metformin, ivermectin, and fluvoxamine to study their effectiveness against outcomes related to COVID-19. They used a...
by Usha Govindarajulu | Aug 17, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
August 17, 2022 In a recent article in Asthma and Allergy, Sohn et al discuss what the impacts were for patients with severe asthma who wore masks during the pandemic in South Korea. Patients in the study were recruited from 5 university hospitals in 3 different...
by Usha Govindarajulu | Aug 3, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
August 3, 2022 In a recent article in BMJ Global Health, James et al discuss a statistical analysis they performed on retrospective data on SARS-CoV-2 infections during the first wave of the COVID-19 pandemic in sub-Saharan African countries using World Health...
by Usha Govindarajulu | Jul 6, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare
July 5, 2022 In a recent article in NPR’s public health page, “Still testing positive after day 10? How to decide when to end your COVID isolation”, Will Stone discusses a big dilemma that many people face which is how long to isolate after they had COVID-19...
by Usha Govindarajulu | Jun 23, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
June 22, 2022 In a recent article in News Medical Lifesciences, they have discussed a recent research paper published as an accepted manuscript in the Clinical Infectious Diseases journal in which the scientists analyzed the population immunity against pre-Omicron and...
by Usha Govindarajulu | Jun 9, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Usha Govindarajulu
June 9, 2022 In a recent article in the Boston Globe by Felicia Freyer, “‘Mild’ Omicron variant was highly lethal, the study finds that at least in Massachusetts, an Eastern state of the United States, that the Omicron variant of COVID-19 was not so mild. A...
